Serious adverse events by total adverse events · patients with upper gastrointestinal bleeding and liver diseases.
Recombinant human factor VII activated showed no clear difference in serious adverse events by total adverse events compared with placebo (high certainty).
1 finding from 1 review
Thromboembolic events · patients with upper gastrointestinal bleeding and liver diseases.
Recombinant human factor VII activated showed no clear difference in thromboembolic events by patients compared with placebo (moderate certainty).
1 finding from 1 review
All‐cause mortality · patients with obstructive jaundice.
It is very uncertain whether pre‐operative biliary drainage changes mortality compared with direct surgery (very low certainty).
1 finding from 1 review
Morbidity ICH‐GCP classification · patients with obstructive jaundice.
It is very uncertain whether pre‐operative biliary drainage changes morbidity ICH‐GCP classification compared with direct surgery (very low certainty).
1 finding from 1 review
Conversion to open cholecystectomy · patients with laparoscopic cholecystectomy.
It is very uncertain whether robotic assistant changes conversion to open cholecystectomy compared with human assistant (very low certainty).
1 finding from 1 review
Operating time · patients with laparoscopic cholecystectomy.
1 finding from 1 review
Intervention not reported
Serious adverse events ‐ Haemodilution versus control. · patients with liver resection.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number requiring allogeneic blood transfusion ‐ Low central venous pressure (CVP) versus control. · patients with liver resection.
It is very uncertain whether the intervention changes number requiring allogeneic blood transfusion ‐ Low central venous… (very low certainty).
1 finding from 1 review
Intervention not reported
Number requiring allogeneic blood transfusion ‐ Haemodilution versus control. · patients with liver resection.
The intervention led to lower number requiring allogeneic blood transfusion ‐ Haemodilution versus…; GRADE not reported.
1 finding from 1 review
Intervention not reported
Red cell transfusion ‐ Low CVP versus control. · patients with liver resection.
1 finding from 1 review
Intervention not reported
Red cell transfusion ‐ Haemodilution versus control. · patients with liver resection.
1 finding from 1 review
Intervention not reported
Mortality ‐ Initial hepatic artery versus initial portal vein reperfusion · patients with liver transplantation.
It is very uncertain whether the intervention changes mortality ‐ Initial hepatic artery versus initial portal vein… (very low certainty).
1 finding from 1 review
Intervention not reported
Graft survival ‐ Retrograde IVC reperfusion versus simultaneous hepatic artery and portal vein reperfusion · patients with liver transplantation.
It is very uncertain whether the intervention changes graft survival ‐ Retrograde IVC reperfusion versus simultaneous… (very low certainty).
1 finding from 1 review
HR 0.88 [0.44, 1.74]
1 study · 1 participants
Very low
Intervention not reported
Mortality ‐ Retrograde IVC reperfusion versus simultaneous hepatic artery and portal vein reperfusion · patients with liver transplantation.
1 finding from 1 review
Intervention not reported
Patient survival ‐ Initial hepatic artery versus initial portal vein reperfusion · patients with liver transplantation.
It is very uncertain whether the intervention changes patient survival ‐ Initial hepatic artery versus initial portal vein… (very low certainty).
1 finding from 1 review
HR 1.03 [0.37, 2.86]
1 study · 1 participants
Very low
Intervention not reported
Patient survival ‐ Simultaneous hepatic artery and portal vein reperfusion versus initial portal vein reperfusion · patients with liver transplantation.
It is very uncertain whether the intervention changes patient survival ‐ Simultaneous hepatic artery and portal vein… (very low certainty).
1 finding from 1 review
HR 0.45 [0.16, 1.28]
1 study · 1 participants
Very low
Intervention not reported
Patient survival ‐ Retrograde IVC reperfusion versus simultaneous hepatic artery and portal vein reperfusion · patients with liver transplantation.
It is very uncertain whether the intervention changes patient survival ‐ Retrograde IVC reperfusion versus simultaneous… (very low certainty).
1 finding from 1 review
HR 1.43 [0.58, 3.53]
1 study · 1 participants
Very low
Intervention not reported
Graft survival ‐ Initial hepatic artery versus initial portal vein flush · patients with liver transplantation.
It is very uncertain whether the intervention changes graft survival ‐ Initial hepatic artery versus initial portal vein… (very low certainty).
1 finding from 1 review
HR 1.05 [0.8, 1.37]
1 study · 1 participants
Very low
Intervention not reported
Graft survival ‐ Additional blood venting through IVC versus no additional blood venting through IVC · patients with liver transplantation.
It is very uncertain whether the intervention changes graft survival ‐ Additional blood venting through IVC versus no… (very low certainty).
1 finding from 1 review
HR 1.15 [0.87, 1.51]
1 study · 1 participants
Very low
Intervention not reported
Graft survival ‐ Initial hepatic artery versus initial portal vein reperfusion · patients with liver transplantation.
It is very uncertain whether the intervention changes graft survival ‐ Initial hepatic artery versus initial portal vein… (very low certainty).
1 finding from 1 review